BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34817074)

  • 1. Targeting arterial partial pressure of carbon dioxide in acute respiratory distress syndrome patients using extracorporeal carbon dioxide removal.
    Leypoldt JK; Kurz J; Echeverri J; Storr M; Harenski K
    Artif Organs; 2022 Apr; 46(4):677-687. PubMed ID: 34817074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling acid-base balance for in-series extracorporeal carbon dioxide removal and continuous venovenous hemofiltration devices.
    Leypoldt JK; Kurz J; Echeverri J; Storr M; Harenski K
    Artif Organs; 2021 Sep; 45(9):1036-1049. PubMed ID: 33909323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal carbon dioxide removal requirements for ultraprotective mechanical ventilation: Mathematical model predictions.
    Leypoldt JK; Goldstein J; Pouchoulin D; Harenski K
    Artif Organs; 2020 May; 44(5):488-496. PubMed ID: 31769043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venovenous extracorporeal CO
    Worku E; Brodie D; Ling RR; Ramanathan K; Combes A; Shekar K
    Perfusion; 2023 Jul; 38(5):1062-1079. PubMed ID: 35656595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of low-flow extracorporeal CO
    Schmidt M; Jaber S; Zogheib E; Godet T; Capellier G; Combes A
    Crit Care; 2018 May; 22(1):122. PubMed ID: 29743094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study.
    Allardet-Servent J; Castanier M; Signouret T; Soundaravelou R; Lepidi A; Seghboyan JM
    Crit Care Med; 2015 Dec; 43(12):2570-81. PubMed ID: 26488219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of extracorporeal carbon dioxide removal combined with continuous blood purification therapy in ARDS with hypercapnia in patients with critical COVID-19.
    Chen Y; Wang S; Huang J; Fu Y; Wen J; Zhou C; Fu Y; Liu L
    Clin Hemorheol Microcirc; 2021; 78(2):199-207. PubMed ID: 33554895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device.
    Tiruvoipati R; Ludski J; Gupta S; Subramaniam A; Ponnapa Reddy M; Paul E; Haji K
    Eur J Med Res; 2023 Aug; 28(1):291. PubMed ID: 37596670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Utilization of Extracorporeal CO2 Removal for Treatment of Acute Respiratory Distress Syndrome Due to Smoke Inhalation and Burns in Sheep.
    Kreyer S; Scaravilli V; Linden K; Belenkiy SM; Necsoiu C; Li Y; Putensen C; Chung KK; Batchinsky AI; Cancio LC
    Shock; 2016 Jan; 45(1):65-72. PubMed ID: 26674455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of PrismaLung+: a novel ECCO
    Hospach I; Goldstein J; Harenski K; Laffey JG; Pouchoulin D; Raible M; Votteler S; Storr M
    Intensive Care Med Exp; 2020 May; 8(1):14. PubMed ID: 32405714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Renal-Pulmonary Extracorporeal Support with Low Blood Flow Techniques: A Retrospective Observational Study (CICERO Study).
    Consales G; Zamidei L; Turani F; Atzeni D; Isoni P; Boscolo G; Saggioro D; Resta MV; Ronco C
    Blood Purif; 2022; 51(4):299-308. PubMed ID: 34237722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of low-flow extracorporeal carbon dioxide removal to facilitate ultra-protective ventilation in patients with moderate acute respiratory distress sindrome.
    Fanelli V; Ranieri MV; Mancebo J; Moerer O; Quintel M; Morley S; Moran I; Parrilla F; Costamagna A; Gaudiosi M; Combes A
    Crit Care; 2016 Feb; 20():36. PubMed ID: 26861596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term feasibility of ultraprotective lung ventilation with low-flow extracorporeal carbon dioxide removal in ARDS patients.
    Chiumello D; Pozzi T; Mereto E; Fratti I; Chiodaroli E; Gattinoni L; Coppola S
    J Crit Care; 2022 Oct; 71():154092. PubMed ID: 35714453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low blood flow carbon dioxide removal system is not effective in a chronic obstructive pulmonary disease exacerbation setting.
    Giraud R; Banfi C; Assouline B; De Charrière A; Bendjelid K
    Artif Organs; 2021 May; 45(5):479-487. PubMed ID: 33184873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial.
    McNamee JJ; Gillies MA; Barrett NA; Perkins GD; Tunnicliffe W; Young D; Bentley A; Harrison DA; Brodie D; Boyle AJ; Millar JE; Szakmany T; Bannard-Smith J; Tully RP; Agus A; McDowell C; Jackson C; McAuley DF;
    JAMA; 2021 Sep; 326(11):1013-1023. PubMed ID: 34463700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study.
    İnal V; Efe S
    Turk J Med Sci; 2021 Aug; 51(4):2127-2135. PubMed ID: 33932971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and outcomes of extracorporeal CO
    Yu TZ; Tatum RT; Saxena A; Ahmad D; Yost CC; Maynes EJ; O'Malley TJ; Massey HT; Swol J; Whitson BA; Tchantchaleishvili V
    Artif Organs; 2022 May; 46(5):763-774. PubMed ID: 34897748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Clinical Application of an Extracorporeal Carbon Dioxide Removal System in Acute Respiratory Distress Syndrome and Acute on Chronic Respiratory Failure.
    Grasselli G; Castagna L; Bottino N; Scaravilli V; Corcione N; Guzzardella A; Bonifazi M; Rossi N; Zanella A; Pesenti A
    ASAIO J; 2020 Jun; 66(6):691-697. PubMed ID: 31425258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design.
    Goligher EC; Combes A; Brodie D; Ferguson ND; Pesenti AM; Ranieri VM; Slutsky AS;
    Intensive Care Med; 2019 Sep; 45(9):1219-1230. PubMed ID: 31432216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal Carbon Dioxide Removal During Continuous Renal Replacement Therapy as Adjunctive Therapy.
    Jacobs R; Sablon A; Spapen H
    Respir Care; 2020 Apr; 65(4):517-524. PubMed ID: 32213601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.